Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TMDX stock hub

TransMedics Group, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TMDXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.3B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TMDX

In the news

Latest news · TMDX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.1

P25 12.6P50 18.3P75 33.7

Trailing P/E15.2

P25 15P50 23.3P75 38.5

ROE45.2

P25 -106.6P50 -46.9P75 -3.1

ROIC13.5

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TMDX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001756262
Company name	TransMedics Group, Inc.
Country	United States
Country code	US
Cusip	89377M109
Employees	898
Employees Change	170%
Employees Change Percent	23.35
Enterprise value	$2.7B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2019-05-02
Isin	US89377M1099
Last refreshed	2026-05-10
Market cap	$2.3B
Market cap category	Mid-Cap
Price	$67.84
Price currency	USD
Rev Per Employee	708,118.04x
Sector	Healthcare
Sic	3845
Symbol	TMDX
Website	https://www.transmedics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.33%
EV Earnings	15.97x
EV Sales Forward	3.49x
EV/EBIT	29.08x
EV/EBITDA	21.91x
EV/FCF	18.14x
EV/Sales	4.32x
FCF yield	6.46%
Forward P/E	27.1x
P/B ratio	4.74x
P/E ratio	15.2x
P/S ratio	3.69x
PE Ratio3 Y	258.26x
PS Forward	2.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.85%
EBITDA Margin	19.71%
FCF margin	23.8%
Gross margin	59.09%
Gross Profit	$375.7M
Gross Profit Growth	29.41%
Gross Profit Growth Q	14.66%
Gross Profit Growth3 Y	66.14%
Gross Profit Growth5 Y	86.65%
Net Income	$171.9M
Net Income Growth	251.23%
Net Income Growth Q	-71.52%
Net Income Growth Years	4%
Pretax Margin	14.05%
Profit Margin	27.04%
Profit Per Employee	$191,452
Profitable Years	2
ROA	5.19
Roa5y	-3.31
ROCE	7.03
ROE	45.22
Roe5y	-4.34
ROIC	13.49
Roic5y	-59.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.21%
Cagr3y	-2.86%
Cagr5y	22.86%
EPS Growth	216.8
EPS Growth Q	-71.52
EPS Growth Years	4
OCF Growth	345.96%
Revenue Growth	30.25x
Revenue Growth Q	21.18x
Revenue Growth Quarters	18x
Revenue Growth Years	9x
Revenue Growth3 Y	74.76x
Revenue Growth5 Y	90.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.56
Assets	$1.4B
Cash	$461.7M
Current Assets	$619.3M
Current Liabilities	$91.9M
Debt	$863.4M
Debt EBITDA	$6.47
Debt Equity	$1.75
Debt FCF	$5.7
Equity	$494M
Interest Coverage	5.4
Liabilities	$940.8M
Long Term Assets	$815.5M
Long Term Liabilities	$848.9M
Net Cash	$-401.7M
Net Cash By Market Cap	$-17.13
Net Debt EBITDA	$3.2
Net Debt Equity	$0.81
Net Debt FCF	$2.65
Tangible Book Value	$482.5M
Tangible Book Value Per Share	$13.97
WACC	11.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.74
Inventory Turnover	5.11
Net Working Capital	$84.1M
Quick ratio	6.01
Working Capital	$527.4M
Working Capital Turnover	$1.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.45%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.19%
200-day SMA	121.9
3Y total return	-8.35%
50-day SMA	112
50-day SMA vs 200-day SMA	50under200
5Y total return	179.87%
All Time High	177.4
All Time High Change	-61.75%
All Time High Date	2024-08-23
All Time Low	10
All Time Low Change	578.4%
All Time Low Date	2022-02-24
ATR	6.8
Beta	2.06
Beta1y	1.69
Beta2y	1.24
Ch YTD	-44.23
High	72.73
High52	156
High52 Date	2025-12-02
High52ch	-56.51%
Low	67.69
Low52	67.69
Low52 Date	2026-05-08
Low52ch	0.22%
Ma50ch	-39.42%
Premarket Change Percent	0.14
Premarket Price	$73
Premarket Volume	9,062
Price vs 200-day SMA	-44.35%
RSI	19.88
RSI Monthly	41.93
RSI Weekly	30.88
Sharpe ratio	-0.33x
Sortino ratio	-0.37
Total Return	-8.45%
Tr YTD	-44.23
Tr1m	-36.79%
Tr1w	-32.17%
Tr3m	-49.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Ratings	Buy
Earnings EPS Estimate	$0.61
Earnings EPS Estimate Growth	-17.57
Earnings Revenue Estimate	174,382,560x
Earnings Revenue Estimate Growth	21.49x
Operating Income	$94.4M
Operating Income Growth	79.82
Operating Income Growth Q	-51.55
Operating margin	14.85
Price target	$131
Price Target Change	$93.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,442,838%
Float Percent	96.76%
Shares Insiders	3.2%
Shares Institutions	109.35%
Shares Out	34,560,911
Shares Qo Q	-11.57%
Shares Yo Y	8.45%
Short Float	22.74%
Short Ratio	7.77
Short Shares	22.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$113.5M
Average Volume	1,493,864.35x
Bv Per Share	14.3
CAPEX	$-68.9M
Ch1m	-36.79
Ch1w	-32.17
Ch1y	-29.19
Ch3m	-49.77
Ch3y	-8.35
Ch5y	179.9
Ch6m	-43.07
Change	-6.94%
Change From Open	-6.48
Close	72.9
Days Gap	-0.49
Depreciation Amortization	30,912,000
Dollar Volume	183,454,149.1
Earnings Date	2026-05-05
Earnings Time	amc
EBIT	$94.4M
EBITDA	$125.3M
EPS	$4.46
F Score	5
FCF	$151.4M
FCF EV Yield	5.51x
FCF Per Share	$4.38
Financing CF	17,591,000
Fiscal Year End	December
Founded	1,998
Goodwill	11,549,000
Graham Number	37.89494
Graham Upside	-44.14
Income Tax	$-82.6M
Investing CF	-68,870,000
Ipr	324
Iprfo	235
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Ma150	123.7
Ma150ch	-45.14%
Ma20	102.3
Ma20ch	-33.67%
Net CF	169,534,000
Next Earnings Date	2026-07-29
Open	72.54
Optionable	Yes
P FCF Ratio	15.49
P OCF Ratio	10.65
Position In Range	2.98
Post Close	67.84
Postmarket Change Percent	0.77
Postmarket Price	$68.36
Ppne	700,974,000
Pre Close	72.9
Price Date	2026-05-08
Price EBITDA	$18.7
Ptbv Ratio	4.86
Relative Volume	1.81x
Revenue	635,890,000x
SBC By Revenue	5.95x
Share Based Comp	37,855,000
Tax By Revenue	-12.99x
Tr6m	-43.07%
Us State	Massachusetts
Views	80
Volume	2,704,218
Z Score	3.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TMDX pay a dividend?

Capital-return profile for this ticker.

Performance

TMDX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TMDX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+109.4%

Float: +96.8% of shares outstanding

Insider ownership

+3.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TMDX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

19.9

Below 30: short-term oversold

Price vs 200-day MA

-44.4%

50/200-day relationship not available

Beta (5Y)

2.06

More volatile than the market

Sharpe ratio

-0.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TMDX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TMDX stock rating?

TransMedics Group, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TMDX analysis?

The full report lives at /stocks/TMDX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TMDX?

The latest report frames TMDX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TMDX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.